Skip to Main Content

Paper Details

Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.
Oncologist
12
2021
Circulating Tumor DNA, FGFR2, MSI, MSI-high ctDNA, Patients, Solid tumors, advanced cancer, blood, cancer, cfDNA, circulating tumor DNA, ctDNA, genes, metastatic gastric cancer, oncology, patient, patients, plasma, plasma cell-free, primary, solid tumors, tumor, tumor tissue
Author NameAffiliation
Shaham Beg
Shaham BegThe Caryl and Israel Englander Institute for Precision Medicine
Erika Hissong
Kentaro Ohara
Kentaro OharaThe Caryl and Israel Englander Institute for Precision Medicine
Michael SigourosThe Caryl and Israel Englander Institute for Precision Medicine
Rohan BarejaInstitute for Computational Biomedicine
Rohan BarejaThe Caryl and Israel Englander Institute for Precision Medicine
Noah GrecoThe Caryl and Israel Englander Institute for Precision Medicine
David WilkesThe Caryl and Israel Englander Institute for Precision Medicine
Scott T Tagawa
Scott T TagawaThe Caryl and Israel Englander Institute for Precision Medicine
Kevin Holcomb
Kevin HolcombThe Caryl and Israel Englander Institute for Precision Medicine
Kenneth EngInstitute for Computational Biomedicine
Kenneth EngThe Caryl and Israel Englander Institute for Precision Medicine
Manish A Shah
Manish A ShahThe Caryl and Israel Englander Institute for Precision Medicine
Nasser K Altorki
Nasser K AltorkiThe Caryl and Israel Englander Institute for Precision Medicine
Andrea Sboner
Andrea SbonerThe Caryl and Israel Englander Institute for Precision Medicine
Andrea SbonerInstitute for Computational Biomedicine
Andrea Sboner
Andrea SbonerInstitute for Computational Biomedicine
Andrea SbonerThe Caryl and Israel Englander Institute for Precision Medicine
David M Nanus
David M NanusThe Caryl and Israel Englander Institute for Precision Medicine
Bishoy M Faltas
Bishoy M Faltas
Bishoy M FaltasThe Caryl and Israel Englander Institute for Precision Medicine
Cora N Sternberg
Cora N SternbergThe Caryl and Israel Englander Institute for Precision Medicine
John SimmonsPersonal Genome Diagnostics Inc.
Ana M Molina
Ana M MolinaThe Caryl and Israel Englander Institute for Precision Medicine
Samuel V AngiuoliPersonal Genome Diagnostics Inc.
Olivier ElementoInstitute for Computational Biomedicine
Olivier ElementoThe Caryl and Israel Englander Institute for Precision Medicine
Olivier ElementoInstitute for Computational Biomedicine
Olivier ElementoThe Caryl and Israel Englander Institute for Precision Medicine
Juan Miguel Mosquera
Juan Miguel MosqueraThe Caryl and Israel Englander Institute for Precision Medicine
Juan Miguel Mosquera
Juan Miguel MosqueraThe Caryl and Israel Englander Institute for Precision Medicine
  • 1 - 45

Datasets

Release 1.2